Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.69 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | CASP3 | P42574 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.65 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.65 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.62 |
| ▸ | APP | P05067 | 4/20 | 0.60 |
| ▸ | AGXT | P21549 | 2/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8929713 | 1.00 | MAOB (0.69) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL8930213 | 1.00 | MAOB (0.69) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL891195 | 1.00 | MAOB (0.69) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL24701846 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL11853089 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL1702909 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL13637020 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL18635916 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL12918621 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 | |
| SCHEMBL16603392 | 0.93 | MAOB (0.62) | MAOBPARP10NPC1RAB9ACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043626-A1 | METHOD FOR THE SELECTIVE CLEAVAGE OF A COMPOUND COMPRISING AN AROMATIC RING AND A C-O-C LINKAGE | RHODIA OPERATIONS (FR) | 2024-02-08 | — | — | US | disclosed |
| EP-4259596-A1 | METHOD FOR SELECTIVE CLEAVAGE OF COMPOUND COMPRISING AROMATIC RING AND C-O-C LINKAGE | SPECIALTY OPERATIONS FRANCE (FR) | 2023-10-18 | — | — | EP | disclosed |
| CN-116648443-A | Method for selectively cleaving a compound comprising an aromatic ring and a C-O-C linkage | 罗地亚经营管理公司 | 2023-08-25 | — | — | CN | disclosed |
| US-11696937-B2 | Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof | SHANGHAI LAIYI CENTER FOR BIOPHARMACEUTICAL R&D CO., LTD. (CN) | 2023-07-11 | — | — | US | disclosed |
| US-11696937-B2 | Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof | SHANGHAI LAIYI CENTER FOR BIOPHARMACEUTICAL R&D CO., LTD. (CN) | 2023-07-11 | — | — | US | disclosed |
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | GALECTIN SCIENCES, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| WO-2022126310-A1 | METHOD FOR SELECTIVE CLEAVAGE OF COMPOUND COMPRISING AROMATIC RING AND C-O-C LINKAGE | RHODIA OPERATIONS (FR) | 2022-06-23 | — | — | WO | disclosed |
| EP-3760633-B1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINAZOLINE TYPE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) | 2021-12-15 | — | — | EP | disclosed |
| US-10988692-B2 | Liquid crystal medium and liquid crystal device | MERCK PATENT GMBH (DE) | 2021-04-27 | — | — | US | disclosed |
| US-20210093691-A1 | Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof | SHANGHAI LAIYI CENTER FOR BIOPHARMACEUTICAL R&D CO., LTD. (CN) | 2021-04-01 | — | — | US | disclosed |
| US-20070054195-A1 | Optical recording medium, method of producing the same, and, optical recording method and optical reproducing method | FUJI PHOTO FILM CO., LTD. | 2007-03-08 | — | — | US | disclosed |
| US-20070047421-A1 | Optical recording method, optical recording apparatus, optical recording medium, and optical reproducing method | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| US-20070047421-A1 | Optical recording method, optical recording apparatus, optical recording medium, and optical reproducing method | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| US-20070047419-A1 | Optical recording method, optical recording apparatus, optical recording medium, and optical reproducing method | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| US-20070047419-A1 | Optical recording method, optical recording apparatus, optical recording medium, and optical reproducing method | FUJI PHOTO FILM CO., LTD. | 2007-03-01 | — | — | US | disclosed |
| US-20070042275-A1 | Composition for optical recording, optical recording medium, and production method thereof | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| US-20070042275-A1 | Composition for optical recording, optical recording medium, and production method thereof | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| EP-0946478-B1 | PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDES, KETONES AND HYDROXAMIC ACID COMPOUNDS | AVENTIS PHARMA INC (US) | 2007-02-14 | — | — | EP | disclosed |
| US-4113782-A | CATALYTIC OXIDATION | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1978-09-12 | — | — | US | disclosed |
| US-3968320-A | Dye solvents for pressure-sensitive record material | MONSANTO COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043626-A1 | METHOD FOR THE SELECTIVE CLEAVAGE OF A COMPOUND COMPRISING AN AROMATIC RING AND A C-O-C LINKAGE | AOC2, AOC1, AOC3 | MAOB 10/4885PARP10 2652/4885NPC1 1827/4885 |
| US-20210093691-A1 | Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof | VIP, CUTA, MGAM | MAOB 2702/4885PARP10 2335/4885NPC1 1225/4885 |
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | LGALS1, LGALS2, LGALS3 | MAOB 1599/4885PARP10 1240/4885NPC1 165/4885 |
| US-11696937-B2 | Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof | VIP, CUTA, MGAM | MAOB 2702/4885PARP10 2335/4885NPC1 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.